iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy

Wesley Jong, JGJV Aerts, S Allard, C Brander, J Buyze, E Florence, B Mothe, J Martinez-Picado, A Olvera, M Rosas, M Salgado, S Moron, J Molto, M Lopez, A Graupera, A Honrado

Research output: Contribution to journalArticleAcademicpeer-review

30 Citations (Scopus)
9 Downloads (Pure)
Original languageUndefined/Unknown
Article number361
Publication statusPublished - 2019

Cite this